Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure.
<h4>Background</h4>Biomarkers predicting tuberculosis treatment response and cure would facilitate drug development. This study investigated expression patterns of the co-stimulation molecule NKG2D in human tuberculosis and treatment to determine its potential usefulness as a host biomar...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0070063 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849724319012225024 |
|---|---|
| author | Syeda S Hassan Jang-Eun Cho Muhammad Akram Katherine L Fielding Hazel M Dockrell Jacqueline M Cliff |
| author_facet | Syeda S Hassan Jang-Eun Cho Muhammad Akram Katherine L Fielding Hazel M Dockrell Jacqueline M Cliff |
| author_sort | Syeda S Hassan |
| collection | DOAJ |
| description | <h4>Background</h4>Biomarkers predicting tuberculosis treatment response and cure would facilitate drug development. This study investigated expression patterns of the co-stimulation molecule NKG2D in human tuberculosis and treatment to determine its potential usefulness as a host biomarker of tuberculosis drug efficacy.<h4>Methods</h4>Tuberculosis patients (n = 26) were recruited in Lahore, Pakistan, at diagnosis and followed up during treatment. Household contacts (n = 24) were also recruited. NKG2D expression was measured by qRT-PCR in RNA samples both ex vivo and following overnight mycobacterial stimulation in vitro. Protein expression of NKG2D and granzyme B was measured by flow cytometry.<h4>Results</h4>NKG2D expression in newly diagnosed tuberculosis patients was similar to household contacts in ex vivo RNA, but was higher following in vitro stimulation. The NKG2D expression was dramatically reduced by intensive phase chemotherapy, in both ex vivo blood RNA and CD8(+) T cell protein expression, but then reverted to higher levels after the continuation phase in successfully treated patients.<h4>Conclusion</h4>The changes in NKG2D expression through successful treatment reflect modulation of the peripheral cytotoxic T cell response. This likely reflects firstly in vivo stimulation by live Mycobacterium tuberculosis, followed by the response to dead bacilli, antigen-release and finally immunopathology resolution. Such changes in host peripheral gene expression, alongside clinical and microbiological indices, could be developed into a biosignature of tuberculosis drug-induced cure to be used in future clinical trials. |
| format | Article |
| id | doaj-art-993a2921def44d65af5d1d6fcc8c742e |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-993a2921def44d65af5d1d6fcc8c742e2025-08-20T03:10:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e7006310.1371/journal.pone.0070063Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure.Syeda S HassanJang-Eun ChoMuhammad AkramKatherine L FieldingHazel M DockrellJacqueline M Cliff<h4>Background</h4>Biomarkers predicting tuberculosis treatment response and cure would facilitate drug development. This study investigated expression patterns of the co-stimulation molecule NKG2D in human tuberculosis and treatment to determine its potential usefulness as a host biomarker of tuberculosis drug efficacy.<h4>Methods</h4>Tuberculosis patients (n = 26) were recruited in Lahore, Pakistan, at diagnosis and followed up during treatment. Household contacts (n = 24) were also recruited. NKG2D expression was measured by qRT-PCR in RNA samples both ex vivo and following overnight mycobacterial stimulation in vitro. Protein expression of NKG2D and granzyme B was measured by flow cytometry.<h4>Results</h4>NKG2D expression in newly diagnosed tuberculosis patients was similar to household contacts in ex vivo RNA, but was higher following in vitro stimulation. The NKG2D expression was dramatically reduced by intensive phase chemotherapy, in both ex vivo blood RNA and CD8(+) T cell protein expression, but then reverted to higher levels after the continuation phase in successfully treated patients.<h4>Conclusion</h4>The changes in NKG2D expression through successful treatment reflect modulation of the peripheral cytotoxic T cell response. This likely reflects firstly in vivo stimulation by live Mycobacterium tuberculosis, followed by the response to dead bacilli, antigen-release and finally immunopathology resolution. Such changes in host peripheral gene expression, alongside clinical and microbiological indices, could be developed into a biosignature of tuberculosis drug-induced cure to be used in future clinical trials.https://doi.org/10.1371/journal.pone.0070063 |
| spellingShingle | Syeda S Hassan Jang-Eun Cho Muhammad Akram Katherine L Fielding Hazel M Dockrell Jacqueline M Cliff Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure. PLoS ONE |
| title | Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure. |
| title_full | Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure. |
| title_fullStr | Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure. |
| title_full_unstemmed | Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure. |
| title_short | Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure. |
| title_sort | modulation of nkg2d expression in human cd8 t cells corresponding with tuberculosis drug cure |
| url | https://doi.org/10.1371/journal.pone.0070063 |
| work_keys_str_mv | AT syedashassan modulationofnkg2dexpressioninhumancd8tcellscorrespondingwithtuberculosisdrugcure AT jangeuncho modulationofnkg2dexpressioninhumancd8tcellscorrespondingwithtuberculosisdrugcure AT muhammadakram modulationofnkg2dexpressioninhumancd8tcellscorrespondingwithtuberculosisdrugcure AT katherinelfielding modulationofnkg2dexpressioninhumancd8tcellscorrespondingwithtuberculosisdrugcure AT hazelmdockrell modulationofnkg2dexpressioninhumancd8tcellscorrespondingwithtuberculosisdrugcure AT jacquelinemcliff modulationofnkg2dexpressioninhumancd8tcellscorrespondingwithtuberculosisdrugcure |